Parnax Lab (506128.BO) Stock Price

Parnax Lab Price

CLOSED
108.35
​
Market closed

Over the last 13 years Parnax Lab grew revenue by 5.5% annually, reaching 1.88 B INR. Earnings per share have grown at 14.3% per year over the last 12 years. For Parnax Lab, the net margin of 6.1% is up versus -0.4% a few years ago.

Parnax Lab stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Parnax Lab business model & stock analysis

Parnax Lab Ltd. generates revenue through manufacturing and exporting pharmaceutical formulations, including cough expectorants, antacids, anti-histamines, multi-vitamins, enzyme preparations, pediatric formulations, geriatric special formulations, highly viscous products, and suspensions. The company trades pharmaceuticals and medicinal products, focusing on high-volume oral formulations for diverse consumer segments. Naxpar Pharma Private Limited serves as its subsidiary in these operations. The firm's primary customers are likely healthcare providers, pharmacies, and distributors within the pharmaceutical industry, though specific buyer details are not disclosed. Parnax Lab Ltd. operates through the pharmaceutical formulations segment, emphasizing export-driven manufacturing and trading activities. Its product portfolio targets various health needs, from pediatric to geriatric care, with a strong focus on oral delivery systems.

Frequently asked questions about Parnax Lab

Converted at the current exchange rate, the Parnax Lab share trades at 1.04 EUR (108.35 INR).

The revenue cannot currently be calculated for Parnax Lab.

The profit cannot currently be calculated for Parnax Lab.

The P/E ratio cannot be calculated for Parnax Lab at the moment.

The P/S cannot be calculated for Parnax Lab currently.

The Eulerpool Quality Score for Parnax Lab is 4/10.

The ISIN of Parnax Lab is INE383L01019. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Parnax Lab is 506128.BO. The ticker symbol is used to trade Parnax Lab shares on the stock exchange.

Fair ValueTerminal
88.85 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
156.45 M INR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Sep 15, 2009
ISIN
INE383L01019
Cusip
Y498DZ107
Market capitalization
1.24 B INRSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
9.68
P/B Ratio
1.50
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
7.55 %
Last updated Nov 14, 2026, 4:02 AM

Parnax Lab Peer Group

Parnax Lab FIGI

PRNX:IN · BBG000D51Y34PRNX:IB · BBG000D51YK5

All fundamentals and in-depth analysis of Parnax Lab

Our stock analysis for Parnax Lab stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Parnax Lab. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.